$Biodesix (BDSX.US)$ Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) Friday, 10th January at 6:00 am LOUISVILLE, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ: BDSX), a leading diagnostic solutions company, today announced its preliminary financial results for the fourth quarter and year ended December 31, 2024 (fiscal 2024). The financial results included in this release pertaining to the fourth quarter and fiscal 2024 are preliminary, u...
$Biodesix (BDSX.US)$ Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study Tuesday, 7th January at 6:00 am LOUISVILLE, Colo., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced a new post-market clinical validation study was published in CHEST Pulmonary Journal that reaffirms the previously established performance of the Nodify CDT® blood-based lung nodule test. Clinical data ...
$Biodesix (BDSX.US)$ Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study Biodesix (Nasdaq: BDSX) announced new data presentation at CHEST 2024 Annual Meeting and launch of a complementary clinical study. The presentation will showcase the use of Nodify Lung® Nodule Risk Assessment in over 35,000 patients in real-world settings. Dr. Kathryn Long will present findings on reclassification rates for lung cancer risk, highlightin...
Gainers: In reaction to earnings/guidance: •$Omnicom Group (OMC.US)$+6.8% (Omnicom reports Q2 EPS $1.68, consensus $1.58) •$Netflix (NFLX.US)$+6.3% (Netflix executives said they expect 1 million new subscribers to join in the third quarter, with revenue forecast to grow to $7.84 billion from $7.48 billion a year ago) •$Fulton Financial (FULT.US)$+4.3% (Fulton Financial reports Q2 EPS 42c, consensus 37c) •$Abbott Laboratories (ABT.US)$+0.6% (Ab...
72779455 : did it beat the estimates?
Jaguar8 OP 72779455 : Yes YoY